Convergent Mechanisms Underlying Reprometabolic Syndrome in Women — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Convergent Mechanisms Underlying Reprometabolic Syndrome in Women — Stella

Recruiting

Back to Infertility, Female trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

University of Colorado School of Medicine, Aurora, Colorado

University of Colorado-School of Medicine, Aurora, Colorado

Key details

Phase

Safety & dosing

Sponsor

University of Colorado, Denver

Collaborators

Colorado Clinical & Translational Sciences Institute

Enrollment target

~20 participants

Started

February 2025

Primary completion

October 2026

Age range

18 Years – 38 Years

Sex

Female only

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov